including the development, production and supply of diagnostic and therapeutic radiopharmaceuticals and radioisotopes.
View moreRelying on a global supply chain system, we can consistently to provide stable and reliable radioisotopes. At the same time, we have developed a variety of new nuclide generators, which can effectively alleviate the supply shortage of short half-life radioisotopes in the market.
Relying on a global supply chain system, we can consistently to provide stable and reliable radioisotopes. At the same time, we have developed a variety of new nuclide generators, which can effectively alleviate the supply shortage of short half-life radioisotopes in the market.
We are developing a series of molecularly targeted products for the diagnosis and treatment of cancer, that will redefine the next generation of radiopharmaceuticals based on product and technology innovations.
View more
Congratulations on the Success of 2024 Annual Conference of Chinese Society of Nuclear Medicine
PET can predict MACE in cardiac sarcoidosis patients
PET tracer performs well in prostate cancer trial
PET/MRI rules out tau protein in late-life depression Will Morton
Tau PET identifies grey matter atrophy in retired athletes
Study explores neurologic problems in Pluvicto patients
